Brief: Chromogenics Q4 Oper Loss Narrows To SEK 11.6 Mln
Feb 17 (Reuters) - ChromoGenics AB CHRO.ST :
* IN Q4 2022, CHROMOGENICS' NET SALES AMOUNTED TO SEK 3.5
(13.7)
MILLION, A DECREASE OF SEK 10.2 MILLION
* CHROMOGENICS' OPERATING LOSS FOR Q4 OF YEAR AMOUNTED TO
SEK
-11.6(-14.7) MILLION
Source text for Eikon: ID:nWkr4mQ9v4
Further company coverage: CHRO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChromoGenics AB
See all newsBrief: Chromogenics Says Conditional Loan Of SEK 47.6 Mln Is Converted To Grant
Brief: Färna Invest Makes SEK 10/Shr Offer For Chromogenics
Brief: Chromogenics Q1 Pre-Tax Loss Widens To SEK 13.6 Mln
Brief: Chromogenics Gets First Order For North America
Brief: Chromogenics Initiates Cost Reduction Program